Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nanosonics.
RELATED STOCKHEAD STORIES
News
Closing Bell: ASX up 1.2pc with power play from tech stocks, surprise dip in jobs
News
Lunch Wrap: ASX rebounds after Powell’s relaxed stance; Nanosonics gets FDA green light
Health & Biotech
Health Check: Join in the Coris as Nanosonics wins key FDA approval
Health & Biotech
Scott Power: ASX health stocks feel force of market volatility
Experts
Criterion: Rollercoaster price movements are now part of the profit-reporting landscape
Health & Biotech
Scott Power: ASX health stocks up in mixed earnings season, Mayne surges on $672 million US buyout
Health & Biotech
Health Check: It’s show-and-tell time for three of our home-grown heroes
Health & Biotech
Scott Power: Cardiac pacing device developer EBR hits Morgans price target amid ‘rotation back into healthcare’
Health & Biotech
Health Check: From feather duster to rooster, Nanosonics again rules the roost
Health & Biotech
Health Check: Local biotech starred in 2024, but the rising tide did not lift all boats
Health & Biotech
Biocurious: Painchek’s aged care and infant market expansion plans could be much-needed salve
Health & Biotech
ASX health stocks fighting superbugs to save lives
Health & Biotech
Health Check: It’s a small world after all for global microcap index additions LTR Pharma and EZZ Life Science
News
ASX Rebalance: Copper in, lithium out as hot biotechs climb ranks
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall in ‘lacklustre’ week
Health & Biotech
ScoPo’s Powerplays: ASX health stocks flat in ‘ocean with no breeze’
News
